USPTO Examiner HAN ROBIN - Art Unit 3786

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
17139285METHOD OF TREATING OBSTRUCTIVE SLEEP APNEA AND SNORING AND A DENTAL APPLIANCE THEREFOREDecember 2020January 2022Allow1210YesNo
17300298SMART MASKSDecember 2020April 2024Abandon4001NoNo
17092897Apparel with Integrated Reusable Health Protective Face Mask and Methods for Wearing SameNovember 2020March 2023Abandon2810NoNo
17083640Multiple Layer MaskOctober 2020September 2023Abandon3510NoNo
17079675DISEASE TRANSMISSION PREVENTING MASSAGE TABLE COVEROctober 2020September 2023Abandon3410NoNo
17030410Anti-Fog Medical Face Mask and A Device for Preventing Formation of Fog on Eyewear while Wearing Face CoverSeptember 2020August 2021Allow1020YesNo
17027345MALE URINARY INCONTINENCE STRIPSeptember 2020September 2024Abandon4711NoNo
17019332FACE SHIELD FOR USE WITH DENTAL LOUPESSeptember 2020November 2021Abandon1480YesNo
17011717RESPIRATORY FACE MASKSeptember 2020September 2023Abandon3611NoNo
16964567Bi-Wing Arm Support SystemJuly 2020March 2025Abandon5650YesYes
16931349PHALANGEAL BRACE AND COLD PACKJuly 2020August 2024Abandon4940YesNo
16888712BREASTFEEDING ASSISTANCE DEVICEMay 2020March 2024Abandon4530NoNo
16882509Apparel with Integrated Reusable Health Protective Face Mask and Methods for Wearing SameMay 2020August 2022Abandon2710NoNo
16757849MEDICAL PROCEDURE SHIELDING DEVICES AND GARMENTSApril 2020September 2022Abandon2901NoNo
16835498INTRA UTERINE DEVICEMarch 2020March 2024Allow4850YesNo
16651095COUGH TREATMENT DEVICEMarch 2020July 2022Abandon2820NoNo
16816947METHOD OF MANUFACTURING HEAD FIXATION DEVICE COMPONENTSMarch 2020May 2024Abandon5121NoNo
16616458Distributive Foot Sleeve for Relieving Pressure in a Ski Boots and the LikeNovember 2019September 2022Abandon3430NoNo
16599676TEXTILE ORTHOSIS HAVING A TABOctober 2019September 2022Abandon3620NoNo
16490506METHOD AND DEVICE FOR PRODUCING AN INTRAUTERINE DEVICEAugust 2019January 2023Abandon4101NoNo
16551832CUSTOMIZABLE WEARABLE TOP TO TREAT SCOLIOSIS IN A PERSONAugust 2019September 2022Abandon3720NoNo
16436202LIMB PROTECTION DEVICEJune 2019November 2021Abandon2920NoNo
16423086SUPPORTS INCLUDING DUAL PIVOT AXES FOR HINGE JOINTMay 2019November 2022Abandon4240NoYes
16349592TONGUE RESTRAINING ORAL APPLIANCEMay 2019December 2022Abandon4320NoNo
16382683DENTAL MOUTH GUARD TO PREVENT BRUXISMApril 2019September 2022Abandon4120NoNo
16286575KNEE-SUPPORTING ASSEMBLY FOR DEGENERATIVE KNEESFebruary 2019December 2020Abandon2120NoNo
16350707Method and apparatus for a customizable hernia compression with breathable substrateDecember 2018August 2020Abandon2001NoNo
16224441DOUBLE-LAYER DRESSING CONTAINING SILK FIBROIN AND A METHOD FOR MAKING THE SAMEDecember 2018August 2023Abandon5641NoNo
16219109Adhesive Bandage with Disposable Abrasive Facings Assembly and a Method of Using the SameDecember 2018October 2022Abandon4661NoNo
16206225CHAFE REDUCTION OR PREVENTION APPARTUS AND METHODNovember 2018March 2022Abandon3930NoNo
16200882ARTICULATED ROD OF AN ORTHOPEDIC DEVICENovember 2018July 2021Allow3200NoNo
16177409ENHANCED MALE PROPHYLACTIC SHIELDOctober 2018April 2021Abandon3010NoNo
16176030SMART GEAR APPARATUSOctober 2018June 2022Abandon4320YesNo
16097417INTRAORAL POSITIONING DEVICEOctober 2018November 2021Abandon3710NoNo
16169909MULTI-DIGIT BRACES AND METHODS OF USEOctober 2018November 2023Allow6020YesYes
16137203Protective Oral Sex Face MaskSeptember 2018December 2021Abandon3840YesNo
16130030EARMUFFSeptember 2018June 2021Abandon3410NoNo
16084359WRIST SUPPORT AND METHODS OF USESeptember 2018April 2022Abandon4320NoNo
16059757SURGICAL POSITIONING SYSTEMAugust 2018February 2023Allow5550YesNo
16074871WOUND DRESSINGS AND METHODSAugust 2018February 2021Abandon3110NoNo
16050226TRI-LAYERED WOUND DRESSING AND METHOD THEREFORJuly 2018February 2021Abandon3110NoNo
16034669MOUTHGUARD INCLUDING BREATHING CHANNELSJuly 2018June 2021Allow3520YesYes
16026043ARM POUCHJuly 2018January 2023Abandon5430YesNo
16067674COMPRESSION STOCKINGJuly 2018March 2024Abandon6060YesNo
16023115ADJUSTABLE MASTOID DRESSING AND METHODJune 2018November 2021Abandon4020NoNo
16061445MOVEMENT RESTRAINING DEVICEJune 2018December 2021Abandon4220NoNo
15993953CUSTOM-FIT DENTAL GUARDMay 2018June 2024Allow6070YesNo
15775555DENTAL ALIGNER, METHOD OF PRODUCTION, AND ORTHOSIS COMPRISING SUCH AN ALIGNERMay 2018May 2021Abandon3611NoNo
15775093PERFUMED DUST MASKMay 2018April 2022Allow4730YesNo
15976329POSTURE SUPPORT DEVICE AND METHOD FOR SUPPORTING POSTUREMay 2018January 2022Allow4520YesNo
15975967RECOIL AND SPINAL ARMOR SUPPORT SYSTEMMay 2018September 2021Allow4120YesNo
15974830STABILIZED EQUINE ANKLE BRACEMay 2018February 2022Allow4540YesNo
15935198Method and Oral Appliance for Improving Air Intake and Reducing BruxismMarch 2018September 2020Allow2910YesNo
15927562ANKLE JOINT MECHANISMMarch 2018March 2022Abandon4830NoNo
15923883SURGICAL DRAPING SYSTEM AND METHODMarch 2018March 2022Allow4830YesNo
15924021SURGICAL STERILIZATION SYSTEM AND METHODMarch 2018June 2022Allow5140YesNo
15756046LOCKING HINGEFebruary 2018October 2022Allow5640YesYes
15904498EAR INSERT FOR RELIEF OF TMJ DISCOMFORT AND METHOD FOR USE THEREOFFebruary 2018March 2022Abandon4830YesNo
15751670Hand Elevation Device and Methods of UseFebruary 2018June 2022Allow5240YesNo
15750691ADJUSTABLE ORTHOTIC FOOT BRACE AND METHOD FOR ADJUSTING A FOOT BRACEFebruary 2018June 2024Abandon6060NoNo
15888073BETTER BITE BLOCKFebruary 2018March 2021Abandon3720YesNo
15749961EYE SHIELD AND MOUNTERFebruary 2018June 2023Abandon6060YesNo
15870801DEVICE FOR PRACTICING AND LEARNING A TREATMENTJanuary 2018August 2022Abandon5540YesNo
15869621PROTECTIVE FACE COVERINGJanuary 2018April 2022Allow5170YesNo
15576362INTRAUTERINE DEVICE WITH A RESTRICTED UPWARD MOVEMENT OF A STRINGNovember 2017March 2021Allow4021YesNo
15558132SUPPLY LINE FOR A ROBOTIC ARM INSTRUMENTSeptember 2017June 2021Abandon4621NoNo
15702282DEVICE FOR FITTING TO A USER'S MANDIBLESeptember 2017October 2020Abandon3710NoNo
15556437SURGICAL DRAPE FOR PATIENT REGISTRATION AND A REGISTRATION METHOD UTILIZING SUCH SURGICAL DRAPESeptember 2017November 2024Abandon6080YesNo
15696885CERVICAL COLLARSeptember 2017May 2022Allow5740YesNo
15555895A Method for Producing a Brace, the Brace as Such, and a Method to Fix the Position of a Broken Bone in a LimbSeptember 2017October 2020Abandon3710NoNo
15554780LIMB SUPPORT AND LIMB SUPPORT FASTENING ARRANGEMENTAugust 2017December 2024Allow6080YesYes
15689127DUAL NOISE ATTENUATION (DNA) HEADSET/EARMUFFAugust 2017May 2022Abandon5740NoNo
15552979FLEXGRIPAugust 2017January 2024Allow6041YesYes
15533864INTRAUTERINE DEVICE (IUD)June 2017March 2022Allow5740YesNo
15531004Respirator NosepieceMay 2017August 2023Abandon6040NoYes
15605650ENHANCED INTRAUTERINE DEVICEMay 2017November 2022Abandon6021NoNo
15530629Traction system and related methodsFebruary 2017June 2023Abandon6051YesNo
15367132DIGIT WRAPPING ASSEMBLY AND METHODDecember 2016June 2022Allow6030YesNo
15295213DEVICES AND METHODS FOR SUPPORTING THE HEAD AND NECKOctober 2016March 2022Abandon6060YesNo
15294110CUSTOMIZABLE KNEE BRACE INTENDED FOR PATIENTS WITH OSTEOARTHRITISOctober 2016July 2021Abandon5760NoNo
15275936POWER-DRIVEN TRACTION DEVICE FOR NECK PHYSICAL THERAPYSeptember 2016November 2020Abandon4930NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner HAN, ROBIN.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
3
Examiner Affirmed
2
(66.7%)
Examiner Reversed
1
(33.3%)
Reversal Percentile
56.4%
Higher than average

What This Means

With a 33.3% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is above the USPTO average, indicating that appeals have better success here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
8
Allowed After Appeal Filing
3
(37.5%)
Not Allowed After Appeal Filing
5
(62.5%)
Filing Benefit Percentile
62.6%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 37.5% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner HAN, ROBIN - Prosecution Strategy Guide

Executive Summary

Examiner HAN, ROBIN works in Art Unit 3786 and has examined 81 patent applications in our dataset. With an allowance rate of 29.6%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 43 months.

Allowance Patterns

Examiner HAN, ROBIN's allowance rate of 29.6% places them in the 5% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by HAN, ROBIN receive 2.94 office actions before reaching final disposition. This places the examiner in the 82% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by HAN, ROBIN is 43 months. This places the examiner in the 18% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +59.9% benefit to allowance rate for applications examined by HAN, ROBIN. This interview benefit is in the 96% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 14.0% of applications are subsequently allowed. This success rate is in the 11% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 0.0% of cases where such amendments are filed. This entry rate is in the 5% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 23% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 62.5% of appeals filed. This is in the 42% percentile among all examiners. Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.

Petition Practice

When applicants file petitions regarding this examiner's actions, 71.4% are granted (fully or in part). This grant rate is in the 77% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 46% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 52% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.